Trial Outcomes & Findings for Optimizing Movement After Anterior Cruciate Ligament Injury (NCT NCT05363683)

NCT ID: NCT05363683

Last Updated: 2025-12-12

Results Overview

Participants completed 3 sets of 5 bilateral bodyweight squats with arms crossed at the chest, with the middle 3 of each set (9 total) averaged and reported. The external knee flexion moment was calculated using an inverse dynamics approach. The interlimb ratio (injured limb / uninjured limb) of the knee flexion moment impulse during descent and ascent of bilateral squatting was analyzed at post-intervention. A value of 1 represents symmetric knee flexion moment impulse; a value less than 1 represents a smaller knee flexion moment impulse in the injured compared to uninjured limb.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

34 participants

Primary outcome timeframe

Immediately post-intervention (within approximately 1 week after completing intervention)

Results posted on

2025-12-12

Participant Flow

Participant milestones

Participant milestones
Measure
Biofeedback Group
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
Provided standard verbal instructions during bilateral squat intervention.
Overall Study
STARTED
16
18
Overall Study
COMPLETED
15
17
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Biofeedback Group
n=16 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Total
n=33 Participants
Total of all reporting groups
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
0 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
0 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Age, Continuous
20.9 Years
STANDARD_DEVIATION 6.6 • n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
19.3 Years
STANDARD_DEVIATION 4.6 • n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
20.1 Years
STANDARD_DEVIATION 5.6 • n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Sex: Female, Male
Female
10 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
5 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
15 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Sex: Female, Male
Male
5 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
12 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
17 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
1 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
1 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Race (NIH/OMB)
Asian
1 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
1 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
2 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Race (NIH/OMB)
Black or African American
1 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
2 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
3 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Race (NIH/OMB)
White
10 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
8 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
18 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Race (NIH/OMB)
More than one race
1 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
1 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
2 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
4 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
6 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
5 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
8 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
12 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
24 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=15 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
0 Participants
n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
0 Participants
n=32 Participants • 1 participant from the control group dropped from the study and did not complete any baseline test; 1 participant from the squat biofeedback group did not complete the demographics survey during baseline testing.
Knee Flexion Moment Impulse at Baseline
0.23 Ratio
STANDARD_DEVIATION 0.19 • n=16 Participants • 1 participant from the control group dropped from the study and did not complete any baseline testing.
0.26 Ratio
STANDARD_DEVIATION 0.16 • n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline testing.
0.25 Ratio
STANDARD_DEVIATION 0.18 • n=33 Participants • 1 participant from the control group dropped from the study and did not complete any baseline testing.
Vertical Ground Reaction Force Impulse at Baseline
0.72 Ratio
STANDARD_DEVIATION 0.11 • n=16 Participants • 1 participant from the control group dropped from the study and did not complete any baseline testing. 1 participant from the squat biofeedback group dropped after part of baseline testing was completed with no follow-up testing completed; therefore, their data was not used as a covariate in ANCOVA analyses.
0.72 Ratio
STANDARD_DEVIATION 0.12 • n=17 Participants • 1 participant from the control group dropped from the study and did not complete any baseline testing. 1 participant from the squat biofeedback group dropped after part of baseline testing was completed with no follow-up testing completed; therefore, their data was not used as a covariate in ANCOVA analyses.
0.72 Ratio
STANDARD_DEVIATION 0.11 • n=33 Participants • 1 participant from the control group dropped from the study and did not complete any baseline testing. 1 participant from the squat biofeedback group dropped after part of baseline testing was completed with no follow-up testing completed; therefore, their data was not used as a covariate in ANCOVA analyses.

PRIMARY outcome

Timeframe: Immediately post-intervention (within approximately 1 week after completing intervention)

Participants completed 3 sets of 5 bilateral bodyweight squats with arms crossed at the chest, with the middle 3 of each set (9 total) averaged and reported. The external knee flexion moment was calculated using an inverse dynamics approach. The interlimb ratio (injured limb / uninjured limb) of the knee flexion moment impulse during descent and ascent of bilateral squatting was analyzed at post-intervention. A value of 1 represents symmetric knee flexion moment impulse; a value less than 1 represents a smaller knee flexion moment impulse in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Knee Flexion Moment Impulse
0.54 Ratio
Standard Deviation 0.28
0.50 Ratio
Standard Deviation 0.21

PRIMARY outcome

Timeframe: Baseline (immediately before intervention, 2-6 weeks after anterior cruciate ligament reconstruction) and 6 months after anterior cruciate ligament reconstruction.

Percent change in cartilage T2 relaxation time will be measured by a magnetic resonance imaging (MRI) scan. A positive percent change represents longer (worse) T2 relaxation times at 6 months compared to baseline testing.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 6 months after anterior cruciate ligament reconstruction.

Participants completed 3 sets of 5 bilateral bodyweight squats with arms crossed at the chest, with the middle 3 of each set (9 total) averaged and reported. The external knee flexion moment was calculated using an inverse dynamics approach. The interlimb ratio (injured limb / uninjured limb) of the knee flexion moment impulse during descent and ascent of bilateral squatting was analyzed at 6 months. A value of 1 represents symmetric knee flexion moment impulse; a value less than 1 represents a smaller knee flexion moment impulse in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Knee Flexion Moment Impulse
0.66 Ratio
Standard Deviation 0.24
0.54 Ratio
Standard Deviation 0.21

SECONDARY outcome

Timeframe: Immediately post-intervention (approximately 1 week after intervention)

Participants completed 3 sets of 5 bilateral bodyweight squats with arms crossed at the chest, with the middle 3 of each set (9 total) averaged and reported. The vertical ground reaction force impulse was calculated. The interlimb ratio (injured limb / uninjured limb) of the vertical ground reaction force impulse during descent and ascent of bilateral squatting was analyzed at post-intervention. A value of 1 represents symmetric vertical ground reaction force impulse; a value less than 1 represents a smaller vertical ground reaction force impulse in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Vertical Ground Reaction Force Impulse
0.91 Ratio
Standard Deviation 0.08
0.84 Ratio
Standard Deviation 0.11

SECONDARY outcome

Timeframe: 6 months after anterior cruciate ligament reconstruction.

Participants completed 3 sets of 5 bilateral bodyweight squats with arms crossed at the chest, with the middle 3 of each set (9 total) averaged and reported. The vertical ground reaction force impulse was calculated. The interlimb ratio (injured limb / uninjured limb) of the vertical ground reaction force impulse during descent and ascent of bilateral squatting was analyzed at 6 months. A value of 1 represents symmetric vertical ground reaction force impulse; a value less than 1 represents a smaller vertical ground reaction force impulse in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Vertical Ground Reaction Force Impulse
0.95 N/A (Ratio)
Standard Deviation 0.08
0.86 N/A (Ratio)
Standard Deviation 0.10

SECONDARY outcome

Timeframe: Immediately post-intervention (within approximately 1 week after completing intervention)

Participants completed 5 valid trials of walking in each limb. The external knee flexion moment was calculated using an inverse dynamics approach. The interlimb ratio (injured limb / uninjured limb) of the peak knee flexion moment during walking was analyzed at post-intervention. A value of 1 represents symmetric peak knee flexion moment; a value less than 1 represents a smaller peak knee flexion moment in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Peak Knee Flexion Moment
0.6 Ratio
Interval 0.2 to 0.8
0.7 Ratio
Interval 0.4 to 0.8

SECONDARY outcome

Timeframe: 6 months after anterior cruciate ligament reconstruction.

Participants completed 5 valid trials of walking in each limb. The external knee flexion moment was calculated using an inverse dynamics approach. The interlimb ratio (injured limb / uninjured limb) of the peak knee flexion moment during walking was analyzed at 6 months. A value of 1 represents symmetric peak knee flexion moment; a value less than 1 represents a smaller peak knee flexion moment in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Peak Knee Flexion Moment
0.7 Ratio
Interval 0.6 to 0.9
0.7 Ratio
Interval 0.6 to 0.9

SECONDARY outcome

Timeframe: Immediately post-intervention (within approximately 1 week after completing intervention)

Participants completed 3 trials of maximal isometric quadriceps strength testing using an isokinetic dynamometer at each limb, with the best trial in each limb used for analysis. The interlimb ratio (injured limb / uninjured limb) of maximum quadriceps strength was analyzed at post-intervention. A value of 1 represents symmetric quadriceps strength; a value less than 1 represents less quadriceps strength in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Quadriceps Strength
0.5 Ratio
Interval 0.4 to 0.6
0.5 Ratio
Interval 0.5 to 0.6

SECONDARY outcome

Timeframe: 6 months after anterior cruciate ligament reconstruction.

Participants completed 3 trials of maximal isometric quadriceps strength testing using an isokinetic dynamometer at each limb, with the best trial in each limb used for analysis. The interlimb ratio (injured limb / uninjured limb) of maximum quadriceps strength was analyzed at 6 months. A value of 1 represents symmetric quadriceps strength; a value less than 1 represents less quadriceps strength in the injured compared to uninjured limb.

Outcome measures

Outcome measures
Measure
Biofeedback Group
n=15 Participants
Provided real-time visual feedback on a screen during bilateral squat intervention.
Control Group
n=17 Participants
Provided standard verbal instructions during bilateral squat intervention.
Quadriceps Strength
0.8 Ratio
Interval 0.5 to 0.8
0.6 Ratio
Interval 0.6 to 0.7

Adverse Events

Biofeedback Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elizabeth Wellsandt

University of Nebraska Medical Center

Phone: 402-559-4309

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place